Abeona Therapeutics (ABEO) Misses Q2 EPS by 4c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $214 thousand versus the consensus estimate of $240 thousand.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Cintas beats estimates but stock edges lower